Total Payments
$26,929
2024 Payments
$17,261
Companies
17
Transactions
53
Medicare Patients
12,624
Medicare Billing
$1.9M
Payment Breakdown by Category
Consulting$20,613 (76.5%)
Travel$3,120 (11.6%)
Other$2,220 (8.2%)
Food & Beverage$703.21 (2.6%)
Education$273.25 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $20,613 | 20 | 76.5% |
| Travel and Lodging | $3,120 | 12 | 11.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,470 | 1 | 5.5% |
| Honoraria | $750.00 | 2 | 2.8% |
| Food and Beverage | $703.21 | 13 | 2.6% |
| Education | $273.25 | 5 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $17,464 | 31 | $0 (2024) |
| SpringWorks Therapeutics, Inc. | $2,070 | 1 | $0 (2024) |
| PFIZER INC. | $1,695 | 4 | $0 (2024) |
| Exelixis Inc. | $1,470 | 1 | $0 (2023) |
| Janssen Biotech, Inc. | $1,470 | 1 | $0 (2024) |
| BeiGene USA, Inc. | $1,200 | 2 | $0 (2024) |
| Daiichi Sankyo Inc. | $750.00 | 2 | $0 (2023) |
| SOBI, INC | $200.00 | 1 | $0 (2024) |
| Amgen Inc. | $112.53 | 1 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $99.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,261 | 30 | AstraZeneca Pharmaceuticals LP ($11,151) |
| 2023 | $3,336 | 4 | AstraZeneca Pharmaceuticals LP ($1,593) |
| 2022 | $5,795 | 10 | AstraZeneca Pharmaceuticals LP ($4,720) |
| 2021 | $119.71 | 3 | Epizyme, Inc., ($82.95) |
| 2020 | $112.53 | 1 | Amgen Inc. ($112.53) |
| 2019 | $297.66 | 4 | Alexion Pharmaceuticals, Inc. ($99.00) |
| 2018 | $7.39 | 1 | Merck Sharp & Dohme Corporation ($7.39) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | Truqap (Drug) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 11/26/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Consulting Fee | Cash or cash equivalent | $675.00 | General |
| Category: Oncology | ||||||
| 11/15/2024 | PFIZER INC. | TIVDAK (Biological) | Travel and Lodging | In-kind items and services | $832.74 | General |
| Category: Oncology | ||||||
| 11/15/2024 | PFIZER INC. | TIVDAK (Biological) | Travel and Lodging | In-kind items and services | $580.90 | General |
| Category: Oncology | ||||||
| 11/15/2024 | PFIZER INC. | TIVDAK (Biological) | Travel and Lodging | In-kind items and services | $189.00 | General |
| Category: Oncology | ||||||
| 11/15/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $92.20 | General |
| Category: Oncology | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 08/07/2024 | SOBI, INC | VONJO (Drug) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 07/24/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Consulting Fee | Cash or cash equivalent | $2,070.00 | General |
| Category: DESMOID TUMORS | ||||||
| 07/02/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 06/30/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $3,950.00 | General |
| Category: Oncology | ||||||
| 06/30/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Travel and Lodging | In-kind items and services | $315.92 | General |
| Category: Oncology | ||||||
| 06/30/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Travel and Lodging | In-kind items and services | $179.67 | General |
| Category: Oncology | ||||||
| 06/30/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Travel and Lodging | In-kind items and services | $87.00 | General |
| Category: Oncology | ||||||
| 06/30/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | Cash or cash equivalent | $64.13 | General |
| Category: Oncology | ||||||
| 06/30/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $56.28 | General |
| Category: Oncology | ||||||
| 06/30/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Travel and Lodging | Cash or cash equivalent | $25.27 | General |
| Category: Oncology | ||||||
| 06/30/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Travel and Lodging | Cash or cash equivalent | $14.00 | General |
| Category: Oncology | ||||||
| 06/28/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Consulting Fee | Cash or cash equivalent | $1,470.00 | General |
| Category: Oncology | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 03/18/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | Cash or cash equivalent | $13.56 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 58 | 2,841 | 52,060 | $1.8M | $287,118 |
| 2022 | 66 | 3,254 | 38,896 | $2.0M | $353,259 |
| 2021 | 66 | 3,183 | 48,275 | $2.0M | $400,044 |
| 2020 | 68 | 3,346 | 53,936 | $3.7M | $871,496 |
Total Patients
12,624
Total Services
193,167
Medicare Billing
$1.9M
Procedure Codes
258
All Medicare Procedures & Services
258 procedure records from CMS Medicare Utilization — Page 1 of 11
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 33 | 47 | $234,107 | $55,675 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 155 | 412 | $89,404 | $36,904 | 41.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 55 | 252 | $156,744 | $23,985 | 15.3% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 39 | 56 | $35,728 | $22,396 | 62.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 59 | 112 | $30,800 | $15,084 | 49.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 157 | 215 | $30,960 | $13,229 | 42.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 13 | 72 | $264,600 | $9,440 | 3.6% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 24 | 25,500 | $153,000 | $9,151 | 6.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 290 | 875 | $52,500 | $9,036 | 17.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 314 | 1,066 | $19,188 | $8,930 | 46.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 310 | 971 | $33,014 | $7,353 | 22.3% |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 14 | 27 | $69,714 | $7,349 | 10.5% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 26 | 42 | $42,252 | $6,752 | 16.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 51 | 134 | $36,984 | $5,973 | 16.2% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 38 | 243 | $33,534 | $5,185 | 15.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $13,986 | $4,740 | 33.9% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 20 | 79 | $23,937 | $3,592 | 15.0% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 36 | 58 | $44,892 | $2,937 | 6.5% |
| 83520 | Measurement of substance using immunoassay technique | Office | 2023 | 27 | 152 | $27,512 | $2,573 | 9.4% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 31 | 260 | $13,520 | $2,369 | 17.5% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 82 | 177 | $9,912 | $2,365 | 23.9% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 38 | 213 | $20,235 | $2,364 | 11.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $5,447 | $2,179 | 40.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 31 | 51 | $5,202 | $1,961 | 37.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 19 | $5,472 | $1,890 | 34.5% |
About Dr. Inder Lal, MD
Dr. Inder Lal, MD is a Internal Medicine healthcare provider based in Amsterdam, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1124227889.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Inder Lal, MD has received a total of $26,929 in payments from pharmaceutical and medical device companies, with $17,261 received in 2024. These payments were reported across 53 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($20,613).
As a Medicare-enrolled provider, Lal has provided services to 12,624 Medicare beneficiaries, totaling 193,167 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 258 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Amsterdam, NY
- Active Since 07/13/2007
- Last Updated 07/01/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1124227889
Products in Payments
- IMFINZI (Biological) $11,436
- CALQUENCE (Drug) $2,860
- OGSIVEO (Drug) $2,070
- TIVDAK (Biological) $1,695
- ENHERTU (Biological) $1,593
- CABOMETYX (Drug) $1,470
- CARVYKTI (Drug) $1,470
- BRUKINSA (Drug) $1,200
- LYNPARZA (Drug) $525.00
- TAGRISSO (Drug) $525.00
- Truqap (Drug) $525.00
- VONJO (Drug) $200.00
- Kyprolis (Drug) $112.53
- SOLIRIS (Drug) $99.00
- TAZVERIK (Drug) $82.95
- Kadcyla (Biological) $81.22
- Rezlidhia (Drug) $73.43
- NINLARO (Drug) $45.45
- PEMAZYRE (Drug) $24.84
- KEYTRUDA (Biological) $7.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Amsterdam
Hafeez Rehman, M.d, M.D
Internal Medicine — Payments: $62,823
Internal Medicine $62,823
Ms. Erika Wachtmeister, D.o, D.O
Internal Medicine — Payments: $6,986
Internal Medicine $6,986
Clara Shnaidman, M.d, M.D
Internal Medicine — Payments: $1,809
Internal Medicine $1,809
Dr. John Fedullo, D. O, D. O
Internal Medicine — Payments: $626.35
Internal Medicine $626.35
Dr. Soo Lee, Md, MD
Internal Medicine — Payments: $585.73
Internal Medicine $585.73
Glenn Pizarro, M.d, M.D
Internal Medicine — Payments: $228.46
Internal Medicine $228.46